Home
Formerly HCRI, the Baim Institute for Clinical Research is a leading, non-profit academic research organization (ARO) that delivers insight, innovation and leadership in today’s dynamic research environment. We collaborate with the world’s most highly respected researchers from renowned institutions to help advance health and quality of life around the world.
450+
Studies managed since 1993
50+
FDA Submissions
250+
Publications
160K+
Enrolled Subjects
Services
Featured Studies
Defining the Clinical Pathway for the Emerging Valve Space
Designing and executing a pivotal clinical trial for a small emerging device company
Health Economics and Quality of Life
Many sponsors seeking for approval for innovative, first-in-class medical devices have found that Economic and Quality of Life (EQoL) studies can be a valuable asset in the overall commercialization process
The DAPT Study: A Case Study in Collaboration
The Dual Antiplatelet Therapy Study (DAPT) was a landmark clinical trial which we designed and managed, with the objective of determining the appropriate duration of dual antiplatelet therapy following placement of a drug-eluting coronary stent.
VIEW ALL STUDIES
Latest from Baim
Baim Institute Names Dr. C. Michael Gibson As CEO
- Event
12.05.17
Pioneering Cardiologist Is Also Entrepreneur And Educator
Mordecai Kramer, MBA Chairing ICI17 Panel
- Event
12.01.17
Baim Institute’s Executive Director of Business Development, Mordecai Kramer, MBA, will be chairing an 8:30 AM panel at ICI Meeting 2017 in Tel Aviv, Israel. The panel title is “Technology Parade I Devices” and is bound to be an interesting discussion. Please see the link below for more information.
Dr. Laura Mauri Interview with Circulation
- Event
11.28.17
Dr. Laura Mauri and colleagues, Circulation’s Editors, Discuss Late Breaking Science. Start at minute 11 for Dr. Mauri’s discussion.
VIEW ALL LATEST FROM BAIM